Sajad Ahmad Malik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sajad Ahmad Malik has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Sajad Ahmad Para
Sher-i-Kashmir Institute of Medical Sciences, Srinagar, India
7 shared publications - Abdul Rouf Khawaja
Department of Urology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, India
6 shared publications - Arif Hamid
Department of Urology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, India
4 shared publications - Arif Hamid Bhat
Sher-i-Kashmir Institute of Medical Sciences, Srinagar, India
4 shared publications - Mohammad Saleem Wani
MCh Scholar Department of Urology and Renal Transplant Sher‐i‐Kashmir Institute of Medical Sciences Srinagar Kashmir India
4 shared publications - Aamir Bashir Raina
Sher-i-Kashmir Institute of Medical Sciences, Srinagar, India
3 shared publications
Latest Publications
- Open Access
- 1 September 2026
- Published by Springer Nature in African Journal of Urology
- Vol. 32 (1) , 62
Erectile Dysfunction in Renal Transplant Recipients: Patterns of Recovery and Determinants of Outcome
Background: Erectile dysfunction (ED) is highly prevalent in men with end-stage renal disease (ESRD) and significantly affects quality of life. Renal transplantation may improve erectile function; however, recovery is often incomplete and influenced by multiple clinical factors. Objectives: To evaluate changes in erectile function following renal transplantation and to identify factors associated with recovery. Methods: This observational study included 41 male renal transplant recipients at a tertiary care center. Erectile function was assessed using the International Index of Erectile Function-5 (IIEF-5) questionnaire before transplantation and at six months post-transplant. Patients were stratified based on baseline ED severity. The association of comorbidities such as diabetes mellitus, hypertension, smoking status and duration of dialysis with post-transplant erectile outcomes was analyzed. Results: Mean IIEF-5 scores improved significantly from 14.6 ± 5.7 before transplantation to 19.1 ± 5.6 at six months post-transplantation ( p < 0.001). The proportion of patients without ED increased from 7.3% to 36.6%, while moderate-to-severe ED decreased substantially. Patients with mild-to-moderate dysfunction demonstrated the greatest improvement, whereas those with severe baseline ED showed limited recovery. Diabetes mellitus, hypertension, smoking and prolonged dialysis duration showed associations with attenuated improvement in erectile function. A subset of patients remained sexually inactive despite objective improvement, indicating that factors beyond physiological recovery may contribute to sexual activity outcomes. Conclusions: Renal transplantation was associated with significant but variable improvement in erectile function. Recovery appears to be associated with baseline ED severity, comorbidities and dialysis exposure. Comprehensive post-transplant care that addresses metabolic, vascular and psychosocial factors may help optimize sexual health outcomes in renal transplant recipients.
- 1 September 2026
- Published by Springer Nature in African Journal of Urology
- Vol. 32 (1) , 62
Open AccessErectile Dysfunction in Renal Transplant Recipients: Patterns of Recovery and Determinants of Outcome
Background: Erectile dysfunction (ED) is highly prevalent in men with end-stage renal disease (ESRD) and significantly affects quality of life. Renal transplantation may improve erectile function; however, recovery is often incomplete and influenced by multiple clinical factors. Objectives: To evaluate changes in erectile function following renal transplantation and to identify factors associated with recovery. Methods: This observational study included 41 male renal transplant recipients at a tertiary care center. Erectile function was assessed using the International Index of Erectile Function-5 (IIEF-5) questionnaire before transplantation and at six months post-transplant. Patients were stratified based on baseline ED severity. The association of comorbidities such as diabetes mellitus, hypertension, smoking status and duration of dialysis with post-transplant erectile outcomes was analyzed. Results: Mean IIEF-5 scores improved significantly from 14.6 ± 5.7 before transplantation to 19.1 ± 5.6 at six months post-transplantation ( p < 0.001). The proportion of patients without ED increased from 7.3% to 36.6%, while moderate-to-severe ED decreased substantially. Patients with mild-to-moderate dysfunction demonstrated the greatest improvement, whereas those with severe baseline ED showed limited recovery. Diabetes mellitus, hypertension, smoking and prolonged dialysis duration showed associations with attenuated improvement in erectile function. A subset of patients remained sexually inactive despite objective improvement, indicating that factors beyond physiological recovery may contribute to sexual activity outcomes. Conclusions: Renal transplantation was associated with significant but variable improvement in erectile function. Recovery appears to be associated with baseline ED severity, comorbidities and dialysis exposure. Comprehensive post-transplant care that addresses metabolic, vascular and psychosocial factors may help optimize sexual health outcomes in renal transplant recipients.
- Open Access
- 13 July 2026
- Published by Springer Nature in African Journal of Urology
- Vol. 32 (1) , 52
Early augmentation cystoplasty in adults with borderline bladder capacity: long-term functional and renal outcomes
Background: Augmentation cystoplasty (AC) is traditionally reserved for end-stage small-capacity bladders. Increasing evidence suggests that earlier intervention in patients with borderline bladder capacity may preserve bladder function and protect the upper urinary tract. We evaluated long-term functional, urodynamic, renal, and quality-of-life outcomes of early augmentation cystoplasty in adults with borderline bladder capacity. Methods: This retrospective observational study included 40 adult patients with borderline bladder capacity (100–170 mL) who underwent open ileocystoplasty at a tertiary referral center between 2015 and 2024. All patients had refractory storage lower urinary tract symptoms despite maximal medical therapy. Pre- and postoperative assessments included urodynamics, renal function, vesicoureteral reflux (VUR), continence status, need for clean intermittent catheterization (CIC), and validated quality-of-life questionnaires. Mean follow-up duration was 6 years. Results: The mean age was 41.2 years; etiologies included neurogenic bladder (45%), genitourinary tuberculosis (42%), post-radiation cystitis (7.5%), and others. Mean bladder capacity increased from 139.6 ± 16.6 mL to 282 ± 12.4 mL ( p < 0.05), and compliance improved from 17 to 40 mL/cm H₂O ( p < 0.05). Mean detrusor filling pressure decreased from 46 to 13.6 cm H₂O ( p < 0.05). Continence was achieved in 95% of patients; 67.5% voided spontaneously and 32.5% required CIC. Serum creatinine improved significantly (1.77 to 1.41 mg/dL; p < 0.05), with no deterioration in renal function during follow-up. Among patients managed without ureteric reimplantation, VUR resolved in 81.3% and downgraded in the remainder. Late complications included bladder stones in 10% and recurrent urinary tract infections in 5%. No malignancy or significant metabolic complications were observed. Conclusions: Early augmentation cystoplasty in adults with borderline bladder capacity provides durable improvement in bladder function, continence, and quality of life, while preserving renal function and effectively resolving pressure-dependent vesicoureteral reflux. Timely surgical intervention, rather than delayed treatment in end-stage disease, may prevent irreversible bladder and renal damage with acceptable long-term morbidity.
- 13 July 2026
- Published by Springer Nature in African Journal of Urology
- Vol. 32 (1) , 52
Open AccessEarly augmentation cystoplasty in adults with borderline bladder capacity: long-term functional and renal outcomes
Background: Augmentation cystoplasty (AC) is traditionally reserved for end-stage small-capacity bladders. Increasing evidence suggests that earlier intervention in patients with borderline bladder capacity may preserve bladder function and protect the upper urinary tract. We evaluated long-term functional, urodynamic, renal, and quality-of-life outcomes of early augmentation cystoplasty in adults with borderline bladder capacity. Methods: This retrospective observational study included 40 adult patients with borderline bladder capacity (100–170 mL) who underwent open ileocystoplasty at a tertiary referral center between 2015 and 2024. All patients had refractory storage lower urinary tract symptoms despite maximal medical therapy. Pre- and postoperative assessments included urodynamics, renal function, vesicoureteral reflux (VUR), continence status, need for clean intermittent catheterization (CIC), and validated quality-of-life questionnaires. Mean follow-up duration was 6 years. Results: The mean age was 41.2 years; etiologies included neurogenic bladder (45%), genitourinary tuberculosis (42%), post-radiation cystitis (7.5%), and others. Mean bladder capacity increased from 139.6 ± 16.6 mL to 282 ± 12.4 mL ( p < 0.05), and compliance improved from 17 to 40 mL/cm H₂O ( p < 0.05). Mean detrusor filling pressure decreased from 46 to 13.6 cm H₂O ( p < 0.05). Continence was achieved in 95% of patients; 67.5% voided spontaneously and 32.5% required CIC. Serum creatinine improved significantly (1.77 to 1.41 mg/dL; p < 0.05), with no deterioration in renal function during follow-up. Among patients managed without ureteric reimplantation, VUR resolved in 81.3% and downgraded in the remainder. Late complications included bladder stones in 10% and recurrent urinary tract infections in 5%. No malignancy or significant metabolic complications were observed. Conclusions: Early augmentation cystoplasty in adults with borderline bladder capacity provides durable improvement in bladder function, continence, and quality of life, while preserving renal function and effectively resolving pressure-dependent vesicoureteral reflux. Timely surgical intervention, rather than delayed treatment in end-stage disease, may prevent irreversible bladder and renal damage with acceptable long-term morbidity.
- Open Access
- 24 June 2025
- Published by AVES YAYINCILIK A.Ş. in Urology Research and Practice
- Vol. 51 (3) , 95-98
Retrieval of Knotted and Stripped Guidewires Lost During Percutaneous Intervention on Kidney—A Case Series and Review of Literature
Objective: The complication associated with percutaneous interventions done on kid neys are usually easily identified and managed with defined protocols. These usually include bleeding, surrounding organ injury, or sepsis. Stripping or knotting of glide wire during these procedures is rare and have no defined management guidelines. There is a paucity in the literature about the management of these complications. A case series is reported on the management of this rare complication. Methods: A case series of 3 patients is presented, with 1 patient experiencing stripping of the glidewire and the other 2 having knotting of glidewire that got stuck during the percutaneous intervention done on the kidney. The guidewires were removed percu taneously with fluoroscopic guidance, thus avoiding the more morbid procedures of open surgery. Results: The stripped and knotted guidewires were removed percutaneously under fluroscopic guidance. we did not report failure or a complication in any of the cases. Conclusion: Stripping or knotting of guidewires is a rare complication occurring during many percutaneous procedures done on kidneys. They can be safely removed percu taneously with fluoroscopic assistance and the use of conventional endoscopic equip ment. Lasers play an indispensable role in the management of these complications Cite this article as: Para SA, Malik SA, Wani!PM, et!al. Retrieval of knotted and stripped guidewires lost during percutaneous intervention on kidney - A!case series and review of literature. Urol Res Pract. 2025;51(3):95-98.
- 24 June 2025
- Published by AVES YAYINCILIK A.Ş. in Urology Research and Practice
- Vol. 51 (3) , 95-98
Open AccessRetrieval of Knotted and Stripped Guidewires Lost During Percutaneous Intervention on Kidney—A Case Series and Review of Literature
Objective: The complication associated with percutaneous interventions done on kid neys are usually easily identified and managed with defined protocols. These usually include bleeding, surrounding organ injury, or sepsis. Stripping or knotting of glide wire during these procedures is rare and have no defined management guidelines. There is a paucity in the literature about the management of these complications. A case series is reported on the management of this rare complication. Methods: A case series of 3 patients is presented, with 1 patient experiencing stripping of the glidewire and the other 2 having knotting of glidewire that got stuck during the percutaneous intervention done on the kidney. The guidewires were removed percu taneously with fluoroscopic guidance, thus avoiding the more morbid procedures of open surgery. Results: The stripped and knotted guidewires were removed percutaneously under fluroscopic guidance. we did not report failure or a complication in any of the cases. Conclusion: Stripping or knotting of guidewires is a rare complication occurring during many percutaneous procedures done on kidneys. They can be safely removed percu taneously with fluoroscopic assistance and the use of conventional endoscopic equip ment. Lasers play an indispensable role in the management of these complications Cite this article as: Para SA, Malik SA, Wani!PM, et!al. Retrieval of knotted and stripped guidewires lost during percutaneous intervention on kidney - A!case series and review of literature. Urol Res Pract. 2025;51(3):95-98.
- Open Access
- 6 October 2024
- Published by Wiley in BJUI Compass
- Vol. 5 (11) , 1183-1194
Integrated enhanced recovery after surgery protocol in radical cystectomy for bladder tumour—A retroprospective study
Introduction: Enhanced recovery after surgery (ERAS) is a patient‐centerd, evidence‐based approach to improve postoperative outcomes. The protocol involves multidisciplinary collaboration and standardisation of perioperative interventions. ERAS has shown positive results in reducing hospitalisation and complications.Methods: The study conducted in the Department of Urology was a retro‐prospective study. It included an ERAS cohort group of 47 patients, studied prospectively from May 2021 to May 2023. These patients were compared to a historical cohort of 47 consecutive patients who underwent radical cystectomy with traditional care before the ERAS pathway was implemented. The primary outcome was hospital length of stay (LOS). Secondary outcomes included perioperative management, time to recovery milestones and complications.Results: Implementation of ERAS pathway for radical cystectomy was associated with reduced hospital LOS (mean LOS 16.19 ± 2.53 days vs. 10.26 ± 3.33 days 7 days; p < 0.0001), reduced time to key recovery milestones, including days to first flatus (3.17 vs. 2.68; p = 0.013) and days to first solid food (5.19 vs. 3.45 p value < 0.0001), first stool (5.53 vs. 4.23; p < 0.0001), reductions in some complications like postoperative ileus (p value = 0.021) and need for total parental nutrition (p value = 0.023).Conclusion: In conclusion, the implementation of the integrated approach facilitates a more efficient recovery process, potentially reducing healthcare costs and enhancing patient comfort.
- 6 October 2024
- Published by Wiley in BJUI Compass
- Vol. 5 (11) , 1183-1194
Open AccessIntegrated enhanced recovery after surgery protocol in radical cystectomy for bladder tumour—A retroprospective study
Introduction: Enhanced recovery after surgery (ERAS) is a patient‐centerd, evidence‐based approach to improve postoperative outcomes. The protocol involves multidisciplinary collaboration and standardisation of perioperative interventions. ERAS has shown positive results in reducing hospitalisation and complications.Methods: The study conducted in the Department of Urology was a retro‐prospective study. It included an ERAS cohort group of 47 patients, studied prospectively from May 2021 to May 2023. These patients were compared to a historical cohort of 47 consecutive patients who underwent radical cystectomy with traditional care before the ERAS pathway was implemented. The primary outcome was hospital length of stay (LOS). Secondary outcomes included perioperative management, time to recovery milestones and complications.Results: Implementation of ERAS pathway for radical cystectomy was associated with reduced hospital LOS (mean LOS 16.19 ± 2.53 days vs. 10.26 ± 3.33 days 7 days; p < 0.0001), reduced time to key recovery milestones, including days to first flatus (3.17 vs. 2.68; p = 0.013) and days to first solid food (5.19 vs. 3.45 p value < 0.0001), first stool (5.53 vs. 4.23; p < 0.0001), reductions in some complications like postoperative ileus (p value = 0.021) and need for total parental nutrition (p value = 0.023).Conclusion: In conclusion, the implementation of the integrated approach facilitates a more efficient recovery process, potentially reducing healthcare costs and enhancing patient comfort.
- Open Access
- 1 May 2023
- Published by AVES YAYINCILIK A.Ş. in Urology Research and Practice
- Vol. 49 (3) , 198-204
Incidence of Ureteric strictures Following Ureteroscopic Laser Lithotripsy: Holmium:YAG Versus Thulium Fiber Laser
Objective: We aimed to compare the incidence of ureteric strictures between holmium:yttrium aluminum garnet and thulium fiber laser following ureteroscopic laser lithotripsy. In the present era of miniaturization of endourologic armamentarium and better optics, how safe are lasers to fire inside ureter? Materials and Methods: It is a prospective comparative study over a period of 2 years that included patients who underwent ureteroscopic laser lithotripsy for ureteric stones. Patients were randomly divided into 2 groups: group A underwent holmium:yttrium aluminum garnet laser lithotripsy and group B underwent thulium fiber laser lithotripsy. Results: A total of 478 patients were analyzed after excluding patients not willing to participate and patients lost to follow-up. Two hundred forty patients underwent holmium:yttrium aluminum garnet laser lithotripsy (group A) and 238 patients underwent thulium fiber laser lithotripsy (group B). The demographic data of 2 groups were comparable. The mean age of patients in group A and group B was 36.5 ± 12.52 years and 38.62 ± 10.71 years, respectively. The mean operative time in group A and group B was 47 ± 15 and 36 ± 13 minutes, respectively, while the mean laser time in group A and group B was 13.5 ± 45 minutes and 9.25 ± 3.2 minutes, respectively. Four (1.67%) patients in group A and 11 (4.62%) patients in group B developed ureteric strictures during follow-up, and the difference was statistically significant (P < .001). The mean length of stricture was 2.67 ± 1.27 cm in group A and 4.42 ± 2.2 cm in group B, and the difference was statistically significant. Conclusion: Thulium fiber laser, projected as safe laser previously, has a higher incidence of ureteric strictures compared to holmium:yttrium aluminum garnet laser when used for ureteroscopic laser lithotripsy. Cite this article as: Ahmad Para S, Saleem Wani M, Hamid A, Ahmad Malik S, Rouf Khawaja A, Mehdi S. Incidence of ureteric strictures following ureteroscopic laser lithotripsy: holmium:YAG versus thulium fiber laser. Urol Res Pract. 2023;49(3):198-204.
- 1 May 2023
- Published by AVES YAYINCILIK A.Ş. in Urology Research and Practice
- Vol. 49 (3) , 198-204
Open AccessIncidence of Ureteric strictures Following Ureteroscopic Laser Lithotripsy: Holmium:YAG Versus Thulium Fiber Laser
Objective: We aimed to compare the incidence of ureteric strictures between holmium:yttrium aluminum garnet and thulium fiber laser following ureteroscopic laser lithotripsy. In the present era of miniaturization of endourologic armamentarium and better optics, how safe are lasers to fire inside ureter? Materials and Methods: It is a prospective comparative study over a period of 2 years that included patients who underwent ureteroscopic laser lithotripsy for ureteric stones. Patients were randomly divided into 2 groups: group A underwent holmium:yttrium aluminum garnet laser lithotripsy and group B underwent thulium fiber laser lithotripsy. Results: A total of 478 patients were analyzed after excluding patients not willing to participate and patients lost to follow-up. Two hundred forty patients underwent holmium:yttrium aluminum garnet laser lithotripsy (group A) and 238 patients underwent thulium fiber laser lithotripsy (group B). The demographic data of 2 groups were comparable. The mean age of patients in group A and group B was 36.5 ± 12.52 years and 38.62 ± 10.71 years, respectively. The mean operative time in group A and group B was 47 ± 15 and 36 ± 13 minutes, respectively, while the mean laser time in group A and group B was 13.5 ± 45 minutes and 9.25 ± 3.2 minutes, respectively. Four (1.67%) patients in group A and 11 (4.62%) patients in group B developed ureteric strictures during follow-up, and the difference was statistically significant (P < .001). The mean length of stricture was 2.67 ± 1.27 cm in group A and 4.42 ± 2.2 cm in group B, and the difference was statistically significant. Conclusion: Thulium fiber laser, projected as safe laser previously, has a higher incidence of ureteric strictures compared to holmium:yttrium aluminum garnet laser when used for ureteroscopic laser lithotripsy. Cite this article as: Ahmad Para S, Saleem Wani M, Hamid A, Ahmad Malik S, Rouf Khawaja A, Mehdi S. Incidence of ureteric strictures following ureteroscopic laser lithotripsy: holmium:YAG versus thulium fiber laser. Urol Res Pract. 2023;49(3):198-204.
- Open Access
- 26 August 2022
- Published by Elsevier in Urology Case Reports
- Vol. 45, 102201
“Collaterals a savior” in superior mesenteric artery injury post radical nephrectomy and retroperitoneal lymph node dissection
- 26 August 2022
- Published by Elsevier in Urology Case Reports
- Vol. 45, 102201
Open Access“Collaterals a savior” in superior mesenteric artery injury post radical nephrectomy and retroperitoneal lymph node dissection
- Open Access
- 5 February 2022
- Published by Elsevier in Urology Case Reports
- Vol. 42, 102027
Prostatic rhabdomyosarcoma in the adult, A case report
- 5 February 2022
- Published by Elsevier in Urology Case Reports
- Vol. 42, 102027
Open AccessProstatic rhabdomyosarcoma in the adult, A case report
- Open Access
- 28 April 2021
- Published by Medip Academy in International Surgery Journal
- Vol. 8 (5) , 1445
Bipolar TURP in high-risk patients with large prostate gland: our experience
Background: The present gold standard monopolar-TURP is associated with a number of complications and has less safety margin in comorbid patients. Bipolar TURP is a modification of conventional M-TURP and has the potential to overcome its most prominent shortcomings with better safety profile in patients with comorbidities. Aim of the study was to evaluate the efficacy of bipolar-TURP in terms of operative and postoperative parameters. Methods: This prospective study was conducted in the department of urology SKIMS Srinagar, from April-2019 to October 2020. Forty-five patients with one or more comorbidities and BHP, with a prostate weight ≥60 gm was evaluated. Operative and postoperative parameters were recorded and patients followed with IPSS and uroflowmetry for a period of 6-months. Results: Of 45 patients who underwent B-TURP, pre-operative parameters were mean age(years) 66.59±9.88, mean prostate size (gm) 77.42±18.4, mean IPSS of 26.3±2.9, mean serum PSA (ng/dl) of 2.32±0.88, mean Qmax (ml/s)of 7.71±2.41 and PVRU of 113.45±16.5 ml. Operative and post-operative parameters were, mean operative time(min) of 68.14±29.6, TUR syndrome in none, mean change in Na+ of -0.98±0.75 meq/l, mean change in Hb of -1.66±0.68 g/dL, mean irrigation time (hours) 24.53±5.46, clot retention in 3 (6.66%) patients, transfusion in 2 (4.44%) patients, mean postoperative catheter time(hours) 69.5±10.5 and mean hospital stay 3.6±1.61 days. Two (4.44%) patients developed stricture urethra and were managed with urethral dilatation. IPSS and Qmax at 6-weeks were 10.2±2.18 and 16.22±2.31 ml and at 6-months were 6.43±1.16 and 19.12±3.14 ml respectively. Conclusions: B-TURP seems to be a more sensible choice for patients with underlying comorbidities or implanted cardiac devices.
- 28 April 2021
- Published by Medip Academy in International Surgery Journal
- Vol. 8 (5) , 1445
Open AccessBipolar TURP in high-risk patients with large prostate gland: our experience
Background: The present gold standard monopolar-TURP is associated with a number of complications and has less safety margin in comorbid patients. Bipolar TURP is a modification of conventional M-TURP and has the potential to overcome its most prominent shortcomings with better safety profile in patients with comorbidities. Aim of the study was to evaluate the efficacy of bipolar-TURP in terms of operative and postoperative parameters. Methods: This prospective study was conducted in the department of urology SKIMS Srinagar, from April-2019 to October 2020. Forty-five patients with one or more comorbidities and BHP, with a prostate weight ≥60 gm was evaluated. Operative and postoperative parameters were recorded and patients followed with IPSS and uroflowmetry for a period of 6-months. Results: Of 45 patients who underwent B-TURP, pre-operative parameters were mean age(years) 66.59±9.88, mean prostate size (gm) 77.42±18.4, mean IPSS of 26.3±2.9, mean serum PSA (ng/dl) of 2.32±0.88, mean Qmax (ml/s)of 7.71±2.41 and PVRU of 113.45±16.5 ml. Operative and post-operative parameters were, mean operative time(min) of 68.14±29.6, TUR syndrome in none, mean change in Na+ of -0.98±0.75 meq/l, mean change in Hb of -1.66±0.68 g/dL, mean irrigation time (hours) 24.53±5.46, clot retention in 3 (6.66%) patients, transfusion in 2 (4.44%) patients, mean postoperative catheter time(hours) 69.5±10.5 and mean hospital stay 3.6±1.61 days. Two (4.44%) patients developed stricture urethra and were managed with urethral dilatation. IPSS and Qmax at 6-weeks were 10.2±2.18 and 16.22±2.31 ml and at 6-months were 6.43±1.16 and 19.12±3.14 ml respectively. Conclusions: B-TURP seems to be a more sensible choice for patients with underlying comorbidities or implanted cardiac devices.
- Open Access
- 1 January 2021
- Published by Medknow in Urology Annals
- Vol. 13 (3) , 210-214
Comparison of percutaneous nephrolithotomy under epidural anesthesia versus general anesthesia: A randomized prospective study
Introduction: PCNL has revolutionized the treatment of renal calculi putting almost an end to the era of open stone surgery. The procedure can safely be carried out under general anesthesia (GA) or regional anesthesia viz. spinal anesthesia (SA), epidural anesthesia (EA) or combined spinal and epidural anesthesia (CSE). Aims and Objectives: We evaluated the surgical outcome after PCNL in two groups of patients randomly divided to undergo procedure under GA or EA. Patients and Methods: Two hundred and thirty patients with American Society of Anesthesiologists (ASA) score <3 were randomly divided into two groups according to the type of anesthesia: i.e. GA (n=110) or EA (n=120). All patients underwent PCNL in prone position. Puncture was done using Bulls eye technique under fluoroscopic guidance and tract dilated using serial dilators up to 24Fr-28 Fr. Demographics, perioperative and postoperative parameters were noted and data analysed. Results: The two groups were comparable in terms of mean age, distribution of stone location, and stone burden. The stone free rate was 90.9% in GA group and 89.2% in EA group and the difference was statistically insignificant (P= 0.659). The requirement for auxiliary procedures was similar between the two groups. A significant difference in pain score was seen in favor of EA group during early post-operative period (P< 0.05). Conclusion: It seems that PCNL can be performed safely and effectively under regional epidural anesthesia with results comparable to general anesthesia with the added advantage of less immediate postoperative pain and analgesic requirement.
- 1 January 2021
- Published by Medknow in Urology Annals
- Vol. 13 (3) , 210-214
Open AccessComparison of percutaneous nephrolithotomy under epidural anesthesia versus general anesthesia: A randomized prospective study
Introduction: PCNL has revolutionized the treatment of renal calculi putting almost an end to the era of open stone surgery. The procedure can safely be carried out under general anesthesia (GA) or regional anesthesia viz. spinal anesthesia (SA), epidural anesthesia (EA) or combined spinal and epidural anesthesia (CSE). Aims and Objectives: We evaluated the surgical outcome after PCNL in two groups of patients randomly divided to undergo procedure under GA or EA. Patients and Methods: Two hundred and thirty patients with American Society of Anesthesiologists (ASA) score <3 were randomly divided into two groups according to the type of anesthesia: i.e. GA (n=110) or EA (n=120). All patients underwent PCNL in prone position. Puncture was done using Bulls eye technique under fluoroscopic guidance and tract dilated using serial dilators up to 24Fr-28 Fr. Demographics, perioperative and postoperative parameters were noted and data analysed. Results: The two groups were comparable in terms of mean age, distribution of stone location, and stone burden. The stone free rate was 90.9% in GA group and 89.2% in EA group and the difference was statistically insignificant (P= 0.659). The requirement for auxiliary procedures was similar between the two groups. A significant difference in pain score was seen in favor of EA group during early post-operative period (P< 0.05). Conclusion: It seems that PCNL can be performed safely and effectively under regional epidural anesthesia with results comparable to general anesthesia with the added advantage of less immediate postoperative pain and analgesic requirement.